Does Dr. RONDEL ALBARADO have financial conflicts of interest?

Dr. RONDEL ALBARADO (M.D.) has received a total of $61,831 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $61,831 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RONDEL ALBARADO?

According to CMS Open Payments data, Dr. RONDEL ALBARADO received funding from ALEXION PHARMACEUTICALS ($61,308), ASTRAZENECA PHARMACEUTICALS ($425), and TELA BIO ($56).

Does Dr. RONDEL ALBARADO receive research grants or speaking fees?

Dr. RONDEL ALBARADO has received $61,831 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RONDEL ALBARADO

M.D.Real-Time Hydrated

Specialty: Surgery, Surgical Critical Care

Practice Location: HOUSTON, TX 77030

NPI Number: 1811187057

LIFETIME INDUSTRY VALUE

$61,831

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ALBARADO is a verified Surgery, Surgical Critical Care practitioner based in HOUSTON, TX.

Between 2021 and 2024, Dr. ALBARADO had an overall industry promotional and research financial footprint of $61,831 as recorded in the federal CMS Open Payments database.

$61,831 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALBARADO's primary funding source is ALEXION PHARMACEUTICALS, which accounts for $61,308 (representing 99.2% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ALEXION PHARMACEUTICALS

Rank 1

$61,308

99.2%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$425

0.7%

TELA BIO

Rank 3

$56

0.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.